article thumbnail

Alzheimer’s therapeutics market to reach $6.8 billion by 2032

European Pharmaceutical Review

According to a report by Future Market Insights (FMI), the global Alzheimer’s therapeutics market is expected to grow at a compound annual growth rate (CAGR) of 9.3 In 2015, Alzheimer’s Therapeutics International found there was an estimated 46.8 percent, and driven largely by collaboration of existing players, reach $6.8

article thumbnail

Low Dose Naltrexone and Hashimoto’s

The Thyroid Pharmacist

In 2015, I conducted a survey of over 2000 readers with Hashimoto’s , asking for the most helpful interventions in their health journeys. However, low doses of this medication (hence, low dose naltrexone or LDN), have been found to modulate the immune system and have shown promise in improving cases of autoimmune disease. Doses of 1.5-4.5

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

GSK partners LifeMine on fungi-derived medicines

pharmaphorum

GlaxoSmithKline has thrown its financial and drug development weight behind LifeMine Therapeutics, a US startup that aims to find new therapeutics from fungi – widely regarded as an underexplored resource of biologically-active compounds. Greg Verdine – LifeMine.

article thumbnail

IO Biotech raises $155m to develop breakthrough cancer vaccine

pharmaphorum

The Series B fundraiser follows the FDA’s decision to grant Breakthrough Therapy designation last month for a combination of its lead immune-oncology therapies IO102 and IO103, with anti-PD-1 monoclonal antibodies for patients with metastatic melanoma.

article thumbnail

Cancer vaccines: providing the edge in oncology

pharmaphorum

According to a report by IQVIA last year, there were 3,500 oncology-focused therapeutic candidates in the pipeline, which represents a 75% increase on figures seen in 2015. Closely related to this is the fact that global spending on oncology drugs reached $164 billion in 2020, with drug sales growing at a compound annual growth rate of 14.3%

Vaccines 134
article thumbnail

8 health benefits of elderberry

The Checkup by Singlecare

Anthocyanin functions as an antioxidant, a compound produced naturally in the body but also present in foods. Elderberry is a good source of vitamin C, which is vital to immune function and helps reduce the severity of cold and flu before it starts,” says Sarah Mathis , MD, a functional medicine coach and CEO of Sarah Mathis Wellness. “It

article thumbnail

Pros and cons of ashwagandha

The Checkup by Singlecare

Studies suggest that certain bioactive compounds in ashwagandha, such as withanolides, may support cognitive function. Supports immune system function Ashwagandha may also help support the immune system, which may be useful for individuals with autoimmune disorders like rheumatoid arthritis, asthma, and atopic dermatitis.

Dosage 52